ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Azoles ∟ Imidazoles ∟ Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide 36 coordinate concepts ∟ 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone \| ∟ Aminoimidazole Carboxamide \| ∟ Antazoline \| ∟ Biotin \| ∟ Carbimazole \| ∟ Cimetidine \| ∟ Clotrimazole \| ∟ Creatinine \| ∟ Dacarbazine \| ∟ Dexmedetomidine \| ∟ Econazole \| ∟ Enoximone \| ∟ Etimizol \| ∟ Etomidate \| ∟ Fadrozole \| ∟ Fluspirilene \| ∟ Histamine \| ∟ Histidinol \| ∟ Idazoxan \| ∟ Imidazolidines \| ∟ Imidazolines \| ∟ Impromidine \| ∟ Levamisole \| ∟ Losartan \| ∟ Medetomidine \| ∟ Methimazole \| ∟ Miconazole \| ∟ Naphazoline \| ∟ Niridazole \| ∟ Nitroimidazoles \| ∟ Ondansetron \| ∟ Oxymetazoline \| ∟ Phentolamine \| ∟ Tetramisole \| ∟ Trimethaphan \| ∟ Urocanic Acid X
Broader terms:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Azoles ∟ Imidazoles ∟ Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide Imidazoles > Azoles > Heterocyclic Compounds, 1-Ring > Heterocyclic Compounds > Medical Subject Headings (MeSH) X
History note:	Disulfides (1972-1974) \| Imidazoles (1972-1990)X
historyNote*:	2002(1975); use IMIDAZOLES 1975-1990 X
publicMeSHNote*:	2002; see FLA 63 1991-2001 & IMIDAZOLES 1975-1990 X
Scope note:	An inhibitor of the last step of noradrenaline biosynthesis. X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1974-11-19X
dateEstablished*:	1991-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	NLMX
Type:	Concept X
Coordinate terms:	4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone \| Aminoimidazole Carboxamide \| Antazoline \| Biotin \| Carbimazole \| Cimetidine \| Clotrimazole \| Creatinine \| Dacarbazine \| Dexmedetomidine \| Econazole \| Enoximone \| Etimizol \| Etomidate \| Fadrozole \| Fluspirilene \| Histamine \| Histidinol \| Idazoxan \| Imidazolidines \| Imidazolines \| Impromidine \| Levamisole \| Losartan \| Medetomidine \| Methimazole \| Miconazole \| Naphazoline \| Niridazole \| Nitroimidazoles \| Ondansetron \| Oxymetazoline \| Phentolamine \| Tetramisole \| Trimethaphan \| Urocanic Acid X
URI:	X
Labels and equivalent concepts:	Bis(4-metyyli-1-homopiperatsiyylitiokarbonyyli)disulfidi) (fi) FLA 63 (fi, replaced) Bis(4-metyl-1-homopiperazinyltiokarbonyl)disulfid (sv) FLA 63 (sv, replaced) X
Share:	X